Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
复制标题
DOI：
10.1093/annonc/mdq194
复制
发表时间：
2010-05-01
影响因子：
50.5
通讯作者：
Warr, D.
中科院分区：
文献类型：
--
作者：
Roila, F.;Herrstedt, J.;Warr, D.
尽管在过去的20年中取得了相关的进展，呕吐，特别是恶心，仍然是癌症化疗的两个最令人痛苦的副作用。20世纪90年代末，一些专业组织发表了关于化疗和放疗患者最佳止吐预防的建议，随后，由于自1997年首次建议以来出现了新的发现和新的止吐药物，2004年，来自几个肿瘤学会的代表在意大利佩鲁贾会面，并更新了止吐指南。2009年6月20日至21日，欧洲肿瘤内科学会（ESMO）和多国癌症支持治疗协会（MASCC）在佩鲁贾组织了第三届止吐药共识会议。本文件报告了这次会议的结果。
Despite the relevant progress achieved in the last 20 years, vomiting and, especially, nausea, continue to be two of the most distressing side-effects of cancer chemotherapy. In the late 1990s several professional organizations published recommendations on the optimal antiemetic prophylaxis in patients submitted to chemotherapy and radiotherapy.Subsequently, due to the emergence of new findings and new antiemetic agents since the first recommendations from 1997, representatives from several oncology societies met in Perugia, Italy, in 2004 and updated the antiemetic guidelines. On 20–21 June 2009 the European Society of Medical Oncology (ESMO) and the Multinational Association of Supportive Care in Cancer (MASCC) organized the third Consensus Conference on antiemetics in Perugia. The results of this Conference are reported in this paper.